Bacterial Pneumonia Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.To Evaluate the Efficacy and Safety of Intravenous Imipenem/Cilastatin/XNW4107 in Comparison With Recarbrio in Adults With HABP /VABP
Condition: Hospital Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia Interventions: Drug: Combination of Imipenem/Cilastatin and XNW4107; Drug: Imipenem/Cilastatin/Relebactam Sponsor: Sinovent Pty Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 24, 2022 Category: Research Source Type: clinical trials
A randomised, double-blind, placebo-controlled, pilot trial of intravenous plasma purified alpha-1 antitrypsin for SARS-CoV-2-induced Acute Respiratory Distress Syndrome: a structured summary of a study protocol for a randomised, controlled trial
AbstractObjectivesThe primary objective is to demonstrate that, in patients with PCR-confirmed SARS-CoV-2 resulting in Acute Respiratory Distress Syndrome (ARDS), administration of 120mg/kg of body weight of intravenous Prolastin ®(plasma-purified alpha-1 antitrypsin) reduces circulating plasma levels of interleukin-6 (IL-6). Secondary objectives are to determine the effects of intravenous Prolastin® on important clinical outcomes including the incidence of adverse events (AEs) and serious adverse events (SAEs).Trial designPhase 2, randomised, double-blind, placebo-controlled, pilot trial.ParticipantsThe study will be co...
Source: Trials - April 19, 2021 Category: Research Source Type: clinical trials
Phase 3 Study to Evaluate the Safety and Efficacy of Omadacycline IV/PO in Adults With Community-Acquired Bacterial Pneumonia
Conditions: Community-acquired Pneumonia; Bacterial Pneumonia Interventions: Drug: Omadacycline; Drug: Moxifloxacin Sponsor: Paratek Pharmaceuticals Inc Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 3, 2021 Category: Research Source Type: clinical trials
